Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;71(3):377-383.
doi: 10.1002/mus.28316. Epub 2024 Dec 24.

Gaps in the Assessment and Care of Neurodevelopmental and Psychiatric Conditions Associated With Dystrophinopathy

Affiliations

Gaps in the Assessment and Care of Neurodevelopmental and Psychiatric Conditions Associated With Dystrophinopathy

Olivia Baldi et al. Muscle Nerve. 2025 Mar.

Abstract

Introduction/aims: While dystrophinopathies are primarily characterized by progressive muscle weakness with onset during childhood, dystrophin also plays a role in brain development. This study aimed to characterize how neurodevelopmental and psychiatric disorders are currently identified and managed in clinical care of those with Becker and Duchenne muscular dystrophy (BDMD).

Methods: Parent Project Muscular Dystrophy (PPMD) disseminated surveys to caregivers and health care providers (HCPs) in the United States to assess the frequency and management of neurodevelopmental and psychiatric disorders of those with dystrophinopathy.

Results: 320 caregivers (C) and 74 HCPs responded to surveys. Caregivers indicated higher rates of neurodevelopmental and psychiatric disorders than HCPs, including anxiety (50.5% C, n = 112; 17.8% HCP, n = 19), attention-deficit hyperactivity disorder (ADHD) (32.0% C, n = 73; 15.9% HCP, n = 17), obsessive-compulsive disorder (OCD) (25.9% C, n = 57; 11.2% HCP, n = 12), depression (21.6% C, n = 48; 18.7% HCP, n = 20), and autism spectrum disorder (ASD) (21.0% C, n = 47; 10.3% HCP, n = 11). Results also indicated gaps in the assessment and care of these conditions, including lack of routine screening, reduced access to psychologists and psychiatrists, and lack of clarity amongst HCPs about who should manage neurodevelopmental and psychiatric concerns in those with dystrophinopathy.

Discussion: Closing the identified gaps in assessment, perception, and care will require increased awareness of neurodevelopmental and psychiatric conditions in dystrophinopathy and screening tools to facilitate early identification of these conditions during routine clinical care.

Keywords: Becker; Duchenne; dystrophinopathy; muscular dystrophy; neuropsychiatry; pediatrics.

PubMed Disclaimer

References

    1. R. Banihani, S. Smile, G. Yoon, et al., “Cognitive and Neurobehavioral Profile in Boys With Duchenne Muscular Dystrophy,” Journal of Child Neurology 30, no. 11 (2015): 1472–1482, https://doi.org/10.1177/0883073815570154.
    1. J. T. Lambert, A. J. Darmahkasih, P. S. Horn, et al., “Neurodevelopmental, Behavioral, and Emotional Symptoms in Becker Muscular Dystrophy,” Muscle & Nerve 61 (2020): 156–162, https://doi.org/10.1002/mus.26750.
    1. V. Ricotti, W. P. L. Mandy, M. Scoto, et al., “Neurodevelopmental, Emotional, and Behavioural Problems in Duchenne Muscular Dystrophy in Relation to Underlying Dystrophin Gene Mutations,” Developmental Medicine and Child Neurology 58 (2016): 77–84, https://doi.org/10.1111/dmcn.12922.
    1. N. Doorenweerd, “Combining Genetics, Neuropsychology and Neuroimaging to Improve Understanding of Brain Involvement in Duchenne Muscular Dystrophy ‐ a Narrative Review,” Neuromuscular Disorders 30 (2020): 437–442, https://doi.org/10.1016/j.nmd.2020.05.001.
    1. V. Preethish‐Kumar, A. Shah, M. Kumar, et al., “In Vivo Evaluation of White Matter Abnormalities in Children With Duchenne Muscular Dystrophy Using DTI,” AJNR. American Journal of Neuroradiology 41 (2020): 1271–1278, https://doi.org/10.3174/AJNR.A6604.

MeSH terms

LinkOut - more resources